Health Reform
OP-ED | When Data Becomes An Excuse To Prevent Change
Data is important. The drumbeat for data-driven policymaking in health care isn’t wrong. Policy decisions that aren’t informed by independent, valid analysis can cause more harm than good. But it’s important to know when we have enough data so we can get to work. Read more
Read MoreResponse: Lobbyist uses seniors and people with disabilities to protect drug company profits
Reading William Smith’s CT Mirror opinion, I was worried that my state had passed draconian laws that were harming the health of seniors and people with disabilities. Thankfully, that isn’t the case. Our anti-discrimination laws are still in place and functioning. . . . True discrimination against seniors and people with disabilities happens every day…
Read MoreCTNJ Opinion: Remember Public Health’s Value After COVID Is Gone
The COVID-19 pandemic has focused a bright light on the weakness of the U.S. public health system. Countries with strong public health systems fared much better in controlling the virus’ spread. America used to have a strong public health system. From 1900 to 2000, life expectancy rose by 30 years. Contrary to public opinion, it…
Read MoreGovernor’s consultant report recommendations for Medicaid savings are baseless
It’s not in the headlines but the biggest source of potential savings, $200 million, proposed by the Governor’s controversial report from Boston Consulting Group (BCG) to save money in state government to is to go back to failed Medicaid financial risk models. There are two problems with the proposal. First, the financial risk models don’t…
Read MoreOpinion: Innovation isn’t helpful if we can’t afford it
In today’s CT Mirror, Jay Gironimi rebuts an opinion supporting the pharmaceutical industry and explains how extreme drug prices are hurting patients. Jay is supporting the Governor’s bill to tax excessive drug price increases years after the companies have recovered their research costs. Jay has Cystic Fibrosis and needs 10-12 medications daily so he can…
Read MoreCTNJ Op-Ed – Drug Innovation Argument Cuts Both Ways
In his recent op-ed, John Burkhardt of Pfizer misses important points when he asserts that the governor’s proposed tax on excessive prescription drug price increases will harm innovation and jobs in Connecticut. He ignores that rising drug prices are making health insurance unaffordable. Overpriced drugs inhibit other innovation and job growth across Connecticut’s economy. He…
Read MoreConnecticut individual plans are profitable
Download the report here Individual coverage in Connecticut, , has been more profitable than most states. From 2011 through 2018, each month $55 of premiums went to profit in Connecticut, the 15th highest profitability among states and above the US average of $47. Individual plans in Massachusetts and New York were far less profitable, while…
Read MoreCost Cap finds hospital system costs driving healthcare spending, but we knew that
Download the report In a surprise to no one, the first analysis by the Cost Cap project finds that inpatient and outpatient hospital services are a main driver of rising healthcare spending in Connecticut. Hospital and drug costs have been identified in multiple studies as the main drivers of rising health costs in our state.…
Read MoreAccessHealthCT report offers roadmap to address disparities
Access Health CT has published a new, very well-researched description, both quantitative and qualitative, of Connecticut’s health disparities and COVID’s impact. The graphic on page 2 following the lives of two boys, Marcus and Tyler, born on the same day but into very different circumstances, makes the impact tangible. I’ll be using it as a…
Read MoreOP-ED | Making the Public Option Better
Commercial health insurance premiums in Connecticut are the sixth highest in the nation and they continue to grow faster than inflation. While we’re making progress, it’s too slow. A public health insurance option to compete with private plans is getting a lot of attention from legislators and it makes sense conceptually. But Connecticut consumers deserve…
Read More